SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-17-000616
Filing Date
2017-03-21
Accepted
2017-03-21 13:16:59
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 REGISTRATION STATEMENT cannabics_s3.htm S-3 206048
2 SPECIMEN STOCK CERTIFICATE cannabics_s3-ex0401.htm EX-4.1 488
3 LEGAL OPINION cannabics_s3-ex0501.htm EX-5.1 9216
4 CONSENT cannabics_s3-ex2301.htm EX-23.1 3141
5 GRAPHIC cannabics_logo.jpg GRAPHIC 3473
6 GRAPHIC backcover.jpg GRAPHIC 15625
7 GRAPHIC ex0401_image1.jpg GRAPHIC 361491
8 GRAPHIC ex0401_image2.jpg GRAPHIC 78128
  Complete submission text file 0001683168-17-000616.txt   852513
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-216845 | Film No.: 17703635
SIC: 2834 Pharmaceutical Preparations